Why a Clinton Win Doesn’t Mean You Should Avoid Pharma Stocks


There has been much made of Democratic candidate for President Hillary Clinton’s stance on the pharmaceutical industry. Over the past week, pharmaceutical stocks have lost between 4-12%, and some has attributed those losses to fear of a Clinton Administration potentially being critical of the industry. Although there is additional regulatory risk with a Clinton win, the US still has an aging population in need of low cost generic drugs. Generics, and especially biosimilars, will likely be in high demand in the US market over the next few years.

Read the source article in The Economic Times

About the Author

Related Posts

Leave a Reply